marijuana stocks news

SHAREHOLDER NOTICE: Goldberg Law PC Announces an Investigation of Claims against GW Pharmaceuticals plc and Advises Investors with Losses in Excess of $100,000 to Contact the Firm

Goldberg Law PC(https://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by GW Pharmaceuticals plc (“GW Pharmaceuticals” or the “Company”) (Nasdaq: GWPH). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased or otherwise acquired GW Pharmaceuticals shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at https://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on whether the Company issued misleading statements and/or failed to disclose that the Company lacked effective internal controls.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at https://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
or
Brian Schall, Esq., 800-977-7401
info@goldberglawpc.com
https://www.Goldberglawpc.com
https://twitter.com/search?q=golberglawpc&src=typd
https://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie Inc. (ABBV) Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients

AbbVie Announces Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with…

$ZDPY Gives Year End Update

Zoned Properties Issues Year End Shareholder Update SCOTTSDALE, Arizona, Dec. 18, 2014…

$AGSTF Now Traded on U.S. OTCQB® Venture Market

Arcturus Now Traded on U.S. OTCQB® Venture Market Arcturus Growthstar Technologies Inc.…